Two character traits associated with adherence to long term therapies

Diabetes Research and Clinical Practice

Volumn 98, Issue 1, 2012, Pages 19-25

  Reach, Gérard ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Adherence; Clinical myopia; Empowerment; Obedience; Patience; Patient education

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADDICTION; DIABETIC PATIENT; DISOBEDIENCE; DOCTOR PATIENT RELATION; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HEALTH CARE PRACTICE; HUMAN; IMPATIENCE; LONG TERM CARE; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT EDUCATION; REVIEW;

CHARACTER; CHOICE BEHAVIOR; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MEDICATION ADHERENCE; POWER (PSYCHOLOGY); QUESTIONNAIRES; SYNDROME;

EID: 84867397878     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.06.008     Document Type: Review

References (60)

1. Germani G., Lazzaro S., Gnoato F., Senzolo M., Borella V., Rupolo G., et al. Nonadherent behaviors after solid organ transplantation. Transplant Proc 2011, 43:318-323.
2. Briesacher B.A., Andrade S.E., Fouayzi H., Chan K.A. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008, 28:437-443.
3. Curtis J.R., Xi J., Westfall A.O., Cheng H., Lyles K., Saag K.G., et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care 2009, 47:334-341.
4. Bramley T.J., Gerbino P.P., Nightengale B.S., Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 Managed Care Organizations. J Manag Care Pharm 2006, 12:239-245.
5. Parris E.S., Lawrence D.B., Mohn L.A., Long L.B. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005, 28:595-599.
6. Lawrence D.B., Ragucci K.R., Long L.B., Parris B.S., Helfer L.A. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006, 12:466-471.
7. Ho P.M., Rumsfeld J.S., Masoudi F.A., McClure D.L., Plomondon M.E., Steiner J.F., et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006, 166:1836-1841.
8. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005, 43:521-530.
9. Lee W.C., Balu S., Cobden D., Joshi A.V., Pashos C.L. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 2006, 19:31-41.
10. WHO Report. Adherence to long-term therapies, evidence for action. WHO Reports. Geneva; 2003, p. 11 [211 p.].
11. Horwitz R.I., Viscoli C.M., Berkman L.F., Berkman L., Donaldson R.M., Horwitz S.M., et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990, 336:542-545.
12. Simpson S.H., Eurich D.T., Majumdar S.R., Padwal R.S., Tsuyuki R.T., Varney J., et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006, 333:15.
13. Avins A.L., Pressman A., Ackerson L., Rudd P., Neuhaus J., Vittinghoff E. Placebo adherence and its association with morbidity and mortality in the Studies of Left Ventricular Dysfunction. J Gen Intern Med 2010, 25:1275-1281.
14. Curtis J.R., Larson J.C., Delzell E., Brookhart M.A., Cadarette S.M., Chlebowski R., et al. Placebo adherence, clinical outcomes, and mortality in the Women's Health Initiative Randomized Hormone Therapy Trial. Med Care 2011, 49:427-435.
15. Curtis J.R., Delzell E., Chen L., Black D., Ensrud K., Judd S., et al. The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the Fracture Intervention Trial. J Bone Miner Res 2011, 26:683-688.
16. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 1987, 94:469-492.
17. Steiner J.F., Ho P.M., Beaty B.L., Dickinson L.M., Hanratty R., Zeng C., et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009, 2:451-457.
18. Karter A.J., Ferrara A., Darbinian J.A., Ackerson L.M., Selby J.V. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 2000, 23:477-483.
19. Aristotle. Nicomachaen Ethics, Book VII, 2, p. 1-2.
20. Kalis A., Mojzisch A., Schweizer T.S., Kaiser S. Weakness of will, akrasia, and the neuropsychiatry of decision making: an interdisciplinary perspective. Cogn Affect Behav Neurosci 2008, 8:402-417.
21. Holton R. How is strength of will possible?. Weakness of will and practical irrationality 2003, 39-67. Clarendon Press, Oxford. S. Stroud, C. Tappolet (Eds.).
22. Loewenstein G. A visceral account of addiction. Getting hooked, rationality and addiction 1999, 236. J. Elster, O.J. Skog (Eds.).
23. Memon S.B., Memon A.M. Why physicians and lay people smoke and how can it be reduced?. J Pak Med Assoc 1999, 49:2-4.
24. Olmsted M.P., McFarlane T. Body weight and body image. BMC Womens Health 2004, 4(Suppl. 1):S5.
25. López-Azpiazu I., Martínez-González M.A., Kearney J., Gibney M., Martínez J.A. Perceived barriers of, and benefits to, healthy eating reported by a Spanish national sample. Public Health Nurs 1999, 2:209-215.
26. Ogden J., Clementi C., Aylwin S. The impact of obesity surgery and the paradox of control: a qualitative study. Psychol Health 2006, 21:273-293.
27. Time and decision, economic and psychological perspectives on intertemporal choice 2003, Russel Sage Foundation, New York. G. Loewenstein, D. Read, R.F. Baumeister (Eds.).
28. Trope Y., Liberman N. Temporal construal. Psychol Rev 2003, 110:403-421.
29. Reach G. Obstacles to patient education in chronic diseases: a transtheoretical analysis. Patient Educ Couns 2009, 77:192-196.
30. Lee R., Taira D.A. Adherence to oral hypoglycemic agents in Hawaii. Prev Chronic Dis 2005, 2:A09.
31. Frederick S. Time preference and personal identity. Time and decision, economic and psychological perspectives on intertemporal choice 2003, 104. Russel Sage Foundation, New York. G. Loewenstein, D. Read, R.F. Baumeister (Eds.).
32. Parfit D. Reasons and persons 1984, Clarendon Press, Oxford, pp. 313-314.
33. Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab 2008, 34:382-385.
34. Wallace M. Future time perspective in schizophrenia. J Abnorm Psychol 1956, 52:240-245.
35. Jones B.A., Landes R.D., Yi R., Bickel W.K. Temporal horizon: modulation by smoking status and gender. Drug Alcohol Depend 2009, 104(Suppl. 1):S87-S93.
36. Gurmankin Levy A., Micco E., Putt M., Armstrong K. Value for the future and breast cancer-preventive health behaviour. Cancer Epidemiol Biomarkers Prev 2006, 15:955-960.
37. Bickel W.K., Yi R., Kowal B.P., Gatchalian K.M. Cigarette smokers discount past and future rewards symmetrically and more than controls: is discounting a measure of impulsivity?. Drug Alcohol Depend 2008, 96:256-262.
38. Perry J.L., Carroll M.E. The role of impulsive behaviour in drug abuse. Psychopharmacology (Berl) 2008, 200:1-26.
39. Weller R.E., Cook E.W.I.I.I., Aswar K.B., Cox J.E. Obese women show greater delay discounting than healthy-weight women. Appetite 2008, 51:563-569.
40. Ikeda S., Kang M.I., Ohtake F. Hyperbolic discounting, the sign effect, and the body mass index. J Health Econ 2010, 29:268-284.
41. Reach G., Michault A., Bihan H., Paulino C., Cohen R., Le Clésiau H. Impatience is an independent determinant of poor diabetes control. Diabetes Metab 2011, 37:497-504.
42. Girerd X., Hanon O., Anagnostopoulos K., Ciupek C., Mourad J.J., Consoli S. Evaluation de l'observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. Presse Med 2001, 30:1044-1048.
43. Elster J., Skog O.J. Getting hooked, rationality and addiction 1999, Cambridge University Press, p. 17.
44. Val/Val genotype. J Neurosci 2007, 27:14383-14391.
45. Kalenscher T., Pennartz C.M. Is a bird in the hand worth two in the future? The neuroeconomics of intertemporal decision-making. Prog Neurobiol 2008, 84:284-315.
46. Bickel W.K., Miller M.L., Yi R., Kowal B.P., Lindquist D.M., Pitcock J.A. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend 2007, 90S:S85-S91.
47. Giedd J.N. Adolescent brain development: vulnerabilities and opportunities. Ann NY Acad Sci 2004, 1021:77-78.
48. Christakou A., Brammer M., Rubia K. Maturation of limbic corticostriatal activation and connectivity associated with developmental changes in temporal discounting. Neuroimage 2011, 54:1344-1354.
49. Stilley C.S., Lawrence K., Bender A., Olshansky E., Webber S.A., Dew M.A. Maturity and adherence in adolescent and young adult heart recipients. Pediatr Transplant 2006, 10:323-330.
50. Mischel W., Shoda Y., Rodriguez M.I. Delay of gratification in children. Science 1989, 244:933-938.
51. Reach G. Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients. Patient Prefer Adherence 2011, 5:523-531.
52. Langlie J.K. Interrelationships among preventive health behaviors: a test of competing hypotheses. Public Health Rep 1979, 94:216-225.
53. Williams A.F., Wechsler H. Interrelationship of preventive actions in health and other areas. Health Serv Rep 1972, 87:969-976.
54. Mohamed N., Mohd Yusoff M., Isah N., Othman I., Syed Rahim S.A., Paiman N. Analysis of factors associated with seatbelt wearing among rear passengers in Malaysia. Int J Inj Contr Saf Promot 2011, 18:3-10.
55. Gillespie G., Al-Natour A., Marcum M., Sheehan H. The prevalence of seatbelt use among pediatric hospital workers. AAOHN J 2010, 58:483-486.
56. Brehm J.W. A theory of psychological reactance 1966, Academic Near, New York.
57. Fogarty J.S. Reactance theory and patient not-compliance. Soc Sci Med 1997, 45:1277-1288.
58. Lutfey K.E., Wishner W.J. Beyond " compliance" is " adherence" Improving the prospect of diabetes care. Diabetes Care 1999, 22:635-639.
59. Beauchamp T., Childress J. Principles of biomedical ethics 2001, Oxford University Press, Oxford, New York, Toronto.
60. Wamala S., Merlo J., Bostrom G., Hogstedt C., Agren G. Socioeconomic disadvantages and primary non-adherence with medication in Sweden. Int J Qual Health Care 2007, 19:134-140.